Henry E. Pelish Nuvalent, Inc. (NUVL) insider trading activity

Henry E. Pelish is Chief Scientific Officer of Nuvalent, Inc.. Currently has a direct ownership of 60,956 shares of NUVL, which is worth approximately $5.22 Million. The most recent transaction as insider was on Jul 10, 2025, when has been sold 5,500 shares (Class A Common Stock) at a price of $80.43 per share, resulting in proceeds of $442,365. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61K

3.4% 3M change

20.42% 12M change

Total Value Held $5.22 Million

Henry E. Pelish Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 10 2025	SELL Open market or private sale	$442,365 $80.43 p/Share	5,500 Reduced 8.28%	60,956 Class A Common Stock
Jul 10 2025	BUY Exercise of conversion of derivative security	$139,535 $25.37 p/Share	5,500 Added 7.64%	66,456 Class A Common Stock
Jul 09 2025	SELL Open market or private sale	$174,796 $81.49 p/Share	2,145 Reduced 3.4%	60,956 Class A Common Stock
Jun 27 2025	SELL Open market or private sale	$173,426 $79.92 p/Share	2,170 Reduced 3.32%	63,101 Class A Common Stock
Jun 27 2025	BUY Exercise of conversion of derivative security	$62,040 $28.59 p/Share	2,170 Added 3.22%	65,271 Class A Common Stock
Jun 25 2025	SELL Open market or private sale	$689,278 $79.87 p/Share	8,630 Reduced 12.03%	63,101 Class A Common Stock
Jun 25 2025	BUY Exercise of conversion of derivative security	$246,731 $28.59 p/Share	8,630 Added 10.74%	71,731 Class A Common Stock
Jun 06 2025	SELL Open market or private sale	$15,963 $79.82 p/Share	200 Reduced 0.32%	63,101 Class A Common Stock
Jun 06 2025	BUY Exercise of conversion of derivative security	$5,718 $28.59 p/Share	200 Added 0.31%	63,301 Class A Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	$2,714 $0.87 p/Share	3,120 Added 4.71%	63,101 Class A Common Stock
Jan 06 2025	SELL Open market or private sale	$197,100 $79.38 p/Share	2,483 Reduced 3.98%	59,981 Class A Common Stock
Jan 06 2025	BUY Grant, award, or other acquisition	-	18,750 Added 23.09%	62,464 Class A Common Stock
Dec 16 2024	BUY Exercise of conversion of derivative security	$7,914 $0.76 p/Share	10,414 Added 19.24%	43,714 Class A Common Stock
Sep 16 2024	SELL Open market or private sale	$3,222,436 $98.26 p/Share	32,795 Reduced 49.62%	33,300 Class A Common Stock
Aug 23 2024	SELL Open market or private sale	$893,340 $85.08 p/Share	10,500 Reduced 13.71%	66,095 Class A Common Stock
Jul 09 2024	BUY Grant, award, or other acquisition	-	13,100 Added 14.61%	76,595 Class A Common Stock

HEP

Henry E. Pelish

Chief Scientific Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVL shares.

Notify only if

Value

Insider Trading

Get notified when an Nuvalent, Inc. insider buys or sells NUVL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nuvalent, Inc.

Track Activities on NUVL

Account